[Hyperbilirubinemia in premature neonates (review of the literature)].
D000138:Acidosis / Q000150:complications; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001663:Bilirubin / Q000378:metabolism; D001803:Blood Transfusion; D004899:Erythroblastosis, Fetal / Q000150:complications; D005260:Female; D005865:Gestational Age; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced; D007019:Hypoproteinemia / Q000150:complications; D000860:Hypoxia / Q000150:complications; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases; D007239:Infections / Q000150:complications; D007263:Infusions, Parenteral; D007567:Jaundice, Neonatal / Q000150:complications / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D007647:Kernicterus / Q000209:etiology; D008099:Liver / Q000378:metabolism; D010789:Phototherapy; D011225:Pre-Eclampsia / Q000150:complications; D011247:Pregnancy; D012459:Salicylates / Q000009:adverse effects; D012709:Serum Albumin / Q000032:analysis; D013256:Steroids / Q000009:adverse effects; D013444:Sulfisoxazole / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D012459:Salicylates; D012709:Serum Albumin; D013256:Steroids; D013444:Sulfisoxazole; D001663:Bilirubin
Giperbilirubinemiia u nedonoshennykh novorozhdennykh deteĭ (obzor literatury.